Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Wordsworth

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Journal of Medical Genetics|July 2, 2010
The revised Ghent nosology for the Marfan syndromeBart L Loeys, Harry C Dietz, Alan C Braverman, et al.
Annals of the Rheumatic Diseases|May 28, 2009
PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian populationMarian L Burr, Haris Naseem, Anne Hinks, et al.
Nature Genetics|September 17, 2008
Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13Anne Barton, Wendy Thomson, Xiayi Ke, et al.
Bonekey Reports|February 7, 2014
Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndromeAideen M McInerney-Leo, Mhairi S Marshall, Brooke Gardiner, et al.
Human Molecular Genetics|May 7, 2009
Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23Gisela Orozco, Anne Hinks, Steve Eyre, et al.
Rheumatology (Oxford, England)|September 11, 2009
Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk lociAnnie McClure, Mark Lunt, Steve Eyre, et al.
Arthritis and Rheumatism|September 12, 2013
Identification of BACH2 and RAD51B as rheumatoid arthritis susceptibility loci in a meta-analysis of genome-wide dataKate McAllister, Annie Yarwood, John Bowes, et al.
Nature Genetics|November 6, 2007
Rheumatoid arthritis association at 6q23Wendy Thomson, Anne Barton, Xiayi Ke, et al.
Lancet (London, England)|September 17, 2013
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trialDominique Baeten, Xenofon Baraliakos, Jürgen Braun, et al.
Cell Genomics|June 30, 2023
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitisAndrew C Brown, Carla J Cohen, Olga Mielczarek, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Journal of Medical Genetics|July 2, 2010
The revised Ghent nosology for the Marfan syndromeBart L Loeys, Harry C Dietz, Alan C Braverman, et al.
Annals of the Rheumatic Diseases|May 28, 2009
PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian populationMarian L Burr, Haris Naseem, Anne Hinks, et al.
Nature Genetics|September 17, 2008
Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13Anne Barton, Wendy Thomson, Xiayi Ke, et al.
Bonekey Reports|February 7, 2014
Whole exome sequencing is an efficient, sensitive and specific method of mutation detection in osteogenesis imperfecta and Marfan syndromeAideen M McInerney-Leo, Mhairi S Marshall, Brooke Gardiner, et al.
Human Molecular Genetics|May 7, 2009
Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23Gisela Orozco, Anne Hinks, Steve Eyre, et al.
Rheumatology (Oxford, England)|September 11, 2009
Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk lociAnnie McClure, Mark Lunt, Steve Eyre, et al.
Arthritis and Rheumatism|September 12, 2013
Identification of BACH2 and RAD51B as rheumatoid arthritis susceptibility loci in a meta-analysis of genome-wide dataKate McAllister, Annie Yarwood, John Bowes, et al.
Nature Genetics|November 6, 2007
Rheumatoid arthritis association at 6q23Wendy Thomson, Anne Barton, Xiayi Ke, et al.
Lancet (London, England)|September 17, 2013
Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trialDominique Baeten, Xenofon Baraliakos, Jürgen Braun, et al.
Cell Genomics|June 30, 2023
Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitisAndrew C Brown, Carla J Cohen, Olga Mielczarek, et al.
Pageof 10